The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...

“All we can do now is give them trazodone two hours before a storm and try to comfort them,” Cantwell said. Anti-anxiety ...

The US Food and Drug Administration recently announced the launch of a regulatory incentive program pilot program, the ...

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

MAXONA Pharmaceuticals today announced that the company has submitted an Investigational New Drug (IND) Application to the ...

Monopar Therapeutics Inc. ('Monopar” or the 'Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, ...

Zydus Lifesciences exceeded expectations in the June quarter with a 6% revenue growth to ₹6,573 crore and a net profit of ...

The FDA accepts a new drug application for vepdegestrant, a promising oral PROTAC developed by Arvinas and Pfizer, signaling ...

A new pill that combats antibiotic-resistant strains of gonorrhoea has inched closer to approval in the US, after the US Food and Drug Administration (FDA) accepted GSK’s gepotidacin for priority ...

The NDA for the gonorrhea indication is supported by data from the EAGLE-1 study, which compared the safety and efficacy of oral gepotidacin to a standard of care combination.

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...

The agency’s new program is designed to increase regulatory predictability and streamline review of domestic manufacturing ...